Table 1 Demographic data and baseline characteristics of study population.
| Â | Non-carrier | TLR2 SNP | TLR4 SNP | P-value |
|---|---|---|---|---|
Number, n | 274 | 13 | 51 | Â |
Gender (M/F) | 200/74 | 8/5 | 38/13 | 0.6236 |
Age, yr (median (IQR)) | 69 (62 to 75) | 74 (66 to 77) | 71 (61 to 77) | 0.1944 |
Weight, kg (median (IQR)) | 80 (70 to 90) | 80 (70 to 93) | 80 (70 to 90) | 0.7685 |
Height, m (median (IQR)) | 1.72 (1.65 to 1.76) | 1.68 (1.65 to 1.72) | 1.73 (1.66 to 1.78) | 0.2200 |
Time of surgery, h | 4.0 (3.4 to 4.7) | 3.8 (3.3 to 4.1) | 3.8 (3.3 to 4.4) | 0.2101 |
Diabetes mellitus, n (%) | 96 (35) | 5 (38) | 12 (24) | 0.2375 |
Admission medication | Â | Â | Â | Â |
   Beta-blocker, n (%) | 215 (78) | 13 (100) | 35 (69) | 0.0362 |
   ACE inhibitor, n (%) | 137 (50) | 10 (77) | 30 (59) | 0.1048 |
   Calcium channel-blocker, n (%) | 39 (14) | 4 (31) | 4 (8) | 0.0862 |
   Diuretics, n (%) | 138 (50) | 5 (38) | 25 (49) | 0.7455 |
   Nitrates, n (%) | 68 (25) | 3 (23) | 11 (22) | 0.9285 |
Type of surgery | Â | Â | Â | Â |
   CABG, n (%) | 183 (67) | 9 (69) | 36 (71) |  |
   VS, n (%) | 33 (12) | 3 (23) | 4 (8) | 0.7542 |
   CABG + VS, n (%) | 43 (16) | 1 (8) | 7 (14) |  |
   Other, n (%) | 15 (6) | 0 (0) | 4 (8) |  |
28-day outcome | Â | Â | Â | Â |
   Survivor, n (%) | 247 (93) | 9 (75) | 41 (89) | 0.0753 |
   Nonsurvivor, n (%) | 19 (7) | 3 (25) | 5(11) |  |